Congress Asset Management Co. lowered its stake in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 2.4% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 396,336 shares of the company’s stock after selling 9,785 shares during the period. Congress Asset Management Co. owned approximately 0.40% of Encompass Health worth $48,151,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in EHC. BlackRock Inc. bought a new stake in Encompass Health in the 2nd quarter worth approximately $1,059,762,000. Dimensional Fund Advisors LP boosted its stake in shares of Encompass Health by 3.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,674,784 shares of the company’s stock worth $162,013,000 after buying an additional 50,647 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in Encompass Health by 1.6% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,182,574 shares of the company’s stock valued at $114,390,000 after acquiring an additional 18,740 shares during the last quarter. William Blair Investment Management LLC bought a new stake in shares of Encompass Health during the 2nd quarter valued at about $116,352,000. Finally, Copeland Capital Management LLC increased its position in shares of Encompass Health by 16.8% during the 1st quarter. Copeland Capital Management LLC now owns 892,823 shares of the company’s stock valued at $86,363,000 after purchasing an additional 128,120 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.
Insider Activity
In related news, EVP John Darby sold 4,858 shares of the business’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $121.09, for a total value of $588,255.22. Following the sale, the executive vice president directly owned 75,041 shares in the company, valued at approximately $9,086,714.69. The trade was a 6.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Mark Tarr sold 173,148 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $125.47, for a total value of $21,724,879.56. Following the transaction, the chief executive officer directly owned 267,814 shares of the company’s stock, valued at approximately $33,602,622.58. The trade was a 39.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 186,912 shares of company stock worth $23,434,845 over the last ninety days. Insiders own 1.80% of the company’s stock.
Encompass Health Price Performance
Encompass Health (NYSE:EHC – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The firm had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.57 billion. During the same quarter last year, the business posted $1.40 earnings per share. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, equities research analysts predict that Encompass Health Corporation will post 6.08 EPS for the current fiscal year.
Encompass Health Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a dividend of $0.21 per share. The ex-dividend date is Thursday, October 1st. This is a positive change from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is 13.68%.
Analysts Set New Price Targets
EHC has been the topic of several recent research reports. Barclays increased their price target on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Truist Financial boosted their price target on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Friday, August 7th. TD Cowen upped their price target on Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Raymond James Financial set a $150.00 price objective on Encompass Health in a research note on Monday, September 28th. Finally, Weiss Ratings raised shares of Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $148.50.
Get Our Latest Analysis on Encompass Health
About Encompass Health
Encompass Health Corporation (NYSE:EHC) is a healthcare services company focused on inpatient rehabilitation. Through its network of rehabilitation hospitals, the company provides intensive medical and therapeutic care to patients recovering from conditions such as strokes, brain and spinal cord injuries, hip fractures, amputations, neurological disorders, and other disabling illnesses or injuries.
Its rehabilitation hospitals offer coordinated care from physicians, nurses, therapists, and other healthcare professionals.
Read More
- Five stocks we like better than Encompass Health
- Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AI
- Lamb Weston’s Turnaround Is Starting to Look Real
- These 3 Stocks Got the Most Love From Analysts in September
- Record French Debt Could Create Opportunities for U.S. Market Operators
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
